Synfacts, Table of Contents

Synfacts 2023; 19(10): 1037
DOI: 10.1055/s-0042-1752791

Innovative Drug Discovery and Development

Identifying the Risk of Formation of Nitrosamines and Other Potentially Mutagenic Impurities during API Manufacture Using In Silico Risk Assessment

Contributor(s):

Antonia F. Stepan (Roche)

,

Jacob W. Greenwood (MSD)